17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Unusual severe hypoxemia due to unilateral pulmonary edema after conventional cardiopulmonary bypass salvaged by veno-venous extracorporeal membrane oxygenation: a case report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          We report a case in which veno-venous extracorporeal membrane oxygenation (V-V ECMO) saved the life of a patient who developed severe hypoxemia due to unusual unilateral pulmonary edema (UPE) after cardiopulmonary bypass (CPB).

          Case presentation

          A 69-year-old man underwent aortic valve replacement and coronary artery bypass grafting. Following uneventful weaning off CPB, he developed severe hypoxemia. The ratio of arterial oxygen tension to inspired oxygen fraction (PaO 2/FiO 2) decreased from 301 mmHg 5 min after CPB to 42 mmHg 90 min after CPB. A chest X-ray revealed right-sided UPE. Immediately established V-V ECMO increased PaO 2/FiO 2 to 170 mmHg. Re-expansion pulmonary edema (REPE) was likely, as the right lung remained collapsed during CPB following the accidental opening of the right chest cavity during graft harvesting.

          Conclusions

          V-V ECMO was effective in improving oxygenation and saving the life of a patient who had fallen into unilateral REPE unusually developing after conventional CPB.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

          Severe acute respiratory failure in adults causes high mortality despite improvements in ventilation techniques and other treatments (eg, steroids, prone positioning, bronchoscopy, and inhaled nitric oxide). We aimed to delineate the safety, clinical efficacy, and cost-effectiveness of extracorporeal membrane oxygenation (ECMO) compared with conventional ventilation support. In this UK-based multicentre trial, we used an independent central randomisation service to randomly assign 180 adults in a 1:1 ratio to receive continued conventional management or referral to consideration for treatment by ECMO. Eligible patients were aged 18-65 years and had severe (Murray score >3.0 or pH 30 cm H(2)O of peak inspiratory pressure) or high FiO(2) (>0.8) ventilation for more than 7 days; intracranial bleeding; any other contraindication to limited heparinisation; or any contraindication to continuation of active treatment. The primary outcome was death or severe disability at 6 months after randomisation or before discharge from hospital. Primary analysis was by intention to treat. Only researchers who did the 6-month follow-up were masked to treatment assignment. Data about resource use and economic outcomes (quality-adjusted life-years) were collected. Studies of the key cost generating events were undertaken, and we did analyses of cost-utility at 6 months after randomisation and modelled lifetime cost-utility. This study is registered, number ISRCTN47279827. 766 patients were screened; 180 were enrolled and randomly allocated to consideration for treatment by ECMO (n=90 patients) or to receive conventional management (n=90). 68 (75%) patients actually received ECMO; 63% (57/90) of patients allocated to consideration for treatment by ECMO survived to 6 months without disability compared with 47% (41/87) of those allocated to conventional management (relative risk 0.69; 95% CI 0.05-0.97, p=0.03). Referral to consideration for treatment by ECMO led to a gain of 0.03 quality-adjusted life-years (QALYs) at 6-month follow-up [corrected]. A lifetime model predicted the cost per QALY of ECMO to be pound19 252 (95% CI 7622-59 200) at a discount rate of 3.5%. We recommend transferring of adult patients with severe but potentially reversible respiratory failure, whose Murray score exceeds 3.0 or who have a pH of less than 7.20 on optimum conventional management, to a centre with an ECMO-based management protocol to significantly improve survival without severe disability. This strategy is also likely to be cost effective in settings with similar services to those in the UK. UK NHS Health Technology Assessment, English National Specialist Commissioning Advisory Group, Scottish Department of Health, and Welsh Department of Health.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) : Guideline from the Extracorporeal Life Support Organization (ELSO)

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Clinical practice. Acute pulmonary edema.

                Bookmark

                Author and article information

                Contributors
                ikawago@juntendo.ac.jp
                Journal
                JA Clin Rep
                JA Clin Rep
                JA Clinical Reports
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                2363-9024
                7 October 2023
                7 October 2023
                December 2023
                : 9
                : 65
                Affiliations
                [1 ]Department of Anesthesiology and Pain Medicine, Juntendo University Hospital, ( https://ror.org/04g0m2d49) Tokyo, 113-8431 Japan
                [2 ]Department of Anesthesia, Fujieda Municipal General Hospital, ( https://ror.org/03q01be91) Shizuoka, Japan
                [3 ]Department of Anesthesiology and Pain Medicine, Juntendo University Shizuoka Hospital, ( https://ror.org/035svbv36) Shizuoka, Japan
                Author information
                http://orcid.org/0000-0002-5791-2700
                Article
                656
                10.1186/s40981-023-00656-2
                10558410
                37803183
                145e4dc6-3d59-444a-bdd0-850f28dd6178
                © The Japanese Society of Anesthesiologists 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 4 September 2023
                : 25 September 2023
                : 26 September 2023
                Categories
                Case Report
                Custom metadata
                © The Japanese Society of Anesthesiologists 2023

                cardiopulmonary bypass,re-expansion pulmonary edema,unilateral pulmonary edema,veno-venous extracorporeal membrane oxygenation

                Comments

                Comment on this article